Conditionally replicative adenoviruses for cancer therapy.
The delineation of the genetic etiology of cancer makes gene therapy a rational approach for the molecular treatment of cancer. Many gene delivery systems have been developed, with viral vectors being the most effective. Underlying cancer gene therapy protocols is the recognition that quantitative tumor transduction cannot be achieved with the vector systems available at the present time. One way to overcome this problem could be to amplify the transduction efficiency through the use of vectors capable of replicating specifically in tumor cells. We are currently developing an adenoviral vector in which viral replication will be restricted to the target tumor cells by limiting the expression of viral genes essential for the virus replication only to the tumor cells of interest.
Curiel
DT
Gene Therapy Program, University of Alabama at Birmingham, 1824 6th Avenue, South, Room 620 Wallace Tumor Institute, Birmingham, AL 35294-3300, USA
Rancourt
C